Mostrar el registro sencillo del ítem
Adaptive changes of the Insig1/SREBP1/SCD1 set point help adipose tissue to cope with increased storage demands of obesity
dc.contributor.author | Carobbio, S. | |
dc.contributor.author | Hagen, R. M. | |
dc.contributor.author | Lelliott, C. J. | |
dc.contributor.author | Slawik, M. | |
dc.contributor.author | Medina-Gomez, G. | |
dc.contributor.author | Tan, C. Y. | |
dc.contributor.author | Sicard, A. | |
dc.contributor.author | Atherton, H. J. | |
dc.contributor.author | Barbarroja, N. | |
dc.contributor.author | Bjursell, M. | |
dc.contributor.author | Bohlooly-Y, M. | |
dc.contributor.author | Virtue, S. | |
dc.contributor.author | Tuthill, A. | |
dc.contributor.author | Lefai, E. | |
dc.contributor.author | Laville, M. | |
dc.contributor.author | Wu, T. | |
dc.contributor.author | Considine, R. V. | |
dc.contributor.author | Vidal, H. | |
dc.contributor.author | Langin, D. | |
dc.contributor.author | Oresic, M. | |
dc.contributor.author | Tinahones, F. J. | |
dc.contributor.author | Fernandez-Real, J. M. | |
dc.contributor.author | Griffin, J. L. | |
dc.contributor.author | Sethi, J. K. | |
dc.contributor.author | López Pérez, Miguel A. | |
dc.contributor.author | Vidal-Puig, A. | |
dc.date.accessioned | 2017-06-07T07:05:23Z | |
dc.date.available | 2017-06-07T07:05:23Z | |
dc.date.issued | 2013 | |
dc.identifier.issn | 0012-1797 | |
dc.identifier.uri | http://hdl.handle.net/20.500.11940/2449 | |
dc.description.abstract | The epidemic of obesity imposes unprecedented challenges on human adipose tissue (WAT) storage capacity that may benefit from adaptive mechanisms to maintain adipocyte functionality. Here, we demonstrate that changes in the regulatory feedback set point control of Insig1/SREBP1 represent an adaptive response that preserves WAT lipid homeostasis in obese and insulin-resistant states. In our experiments, we show that Insig1 mRNA expression decreases in WAT from mice with obesity-associated insulin resistance and from morbidly obese humans and in in vitro models of adipocyte insulin resistance. Insig1 downregulation is part of an adaptive response that promotes the maintenance of SREBP1 maturation and facilitates lipogenesis and availability of appropriate levels of fatty acid unsaturation, partially compensating the antilipogenic effect associated with insulin resistance. We describe for the first time the existence of this adaptive mechanism in WAT, which involves Insig1/SREBP1 and preserves the degree of lipid unsaturation under conditions of obesity-induced insulin resistance. These adaptive mechanisms contribute to maintain lipid desaturation through preferential SCD1 regulation and facilitate fat storage in WAT, despite on-going metabolic stress. | |
dc.language.iso | eng | |
dc.subject.mesh | 3T3-L1 Cells | |
dc.subject.mesh | Adaptation, Physiological | |
dc.subject.mesh | Adipose Tissue, White | |
dc.subject.mesh | Animals | |
dc.subject.mesh | Down-Regulation | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Insulin Resistance | |
dc.subject.mesh | Lipid Metabolism | |
dc.subject.mesh | Membrane Proteins | |
dc.subject.mesh | Mice | |
dc.subject.mesh | Mice, Knockout | |
dc.subject.mesh | Obesity | |
dc.subject.mesh | Obesity, Morbid | |
dc.subject.mesh | RNA, Messenger | |
dc.subject.mesh | Stearoyl-CoA Desaturase | |
dc.subject.mesh | Sterol Regulatory Element Binding Protein 1 | |
dc.title | Adaptive changes of the Insig1/SREBP1/SCD1 set point help adipose tissue to cope with increased storage demands of obesity | |
dc.type | Artigo | es |
dc.authorsophos | Carobbio, S. | |
dc.authorsophos | Hagen, R. M. | |
dc.authorsophos | Lelliott, C. J. | |
dc.authorsophos | Slawik, M. | |
dc.authorsophos | Medina-Gomez, G. | |
dc.authorsophos | Tan, C. Y. | |
dc.authorsophos | Sicard, A. | |
dc.authorsophos | Atherton, H. J. | |
dc.authorsophos | Barbarroja, N. | |
dc.authorsophos | Bjursell, M. | |
dc.authorsophos | Bohlooly-Y, M. | |
dc.authorsophos | Virtue, S. | |
dc.authorsophos | Tuthill, A. | |
dc.authorsophos | Lefai, E. | |
dc.authorsophos | Laville, M. | |
dc.authorsophos | Wu, T. | |
dc.authorsophos | Considine, R. V. | |
dc.authorsophos | Vidal, H. | |
dc.authorsophos | Langin, D. | |
dc.authorsophos | Oresic, M. | |
dc.authorsophos | Tinahones, F. J. | |
dc.authorsophos | Fernandez-Real, J. M. | |
dc.authorsophos | Griffin, J. L. | |
dc.authorsophos | Sethi, J. K. | |
dc.authorsophos | López, M. | |
dc.authorsophos | Vidal-Puig, A. | |
dc.identifier.doi | 10.2337/db12-1748 | |
dc.identifier.isi | 326290700013 | |
dc.identifier.pmid | 23919961 | |
dc.identifier.sophos | 13187 | |
dc.issue.number | 11 | |
dc.journal.title | DIABETES | |
dc.organization | Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago::IDIS.- Instituto de investigaciones sanitarias de Santiago | |
dc.page.initial | 3697 | |
dc.page.final | 3708 | |
dc.relation.publisherversion | https://diabetes.diabetesjournals.org/content/diabetes/62/11/3697.full.pdf | |
dc.rights.accessRights | openAccess | |
dc.typesophos | Artículo Original | |
dc.volume.number | 62 |